Karen J. Ferrante

1.5k citations
18 papers · 1.2k indexed · 1 hit paper · h-index 9
Topics
Prostate Cancer Treatment and Research (8 papers)Estrogen and related hormone effects (5 papers)Hormonal and reproductive studies (4 papers)

In The Last Decade

Karen J. Ferrante

18 papers receiving 1.2k citations

Hit Papers

Phase I and Pharmacologic Study of OSI-774, an Epidermal ...20012026200920172001250500750

Peers

Karen J. Ferrante
Comparison fields: 5 of 84
  • Oncology 862
  • Pulmonary and Respiratory Medicine 741
  • Molecular Biology 354
  • Cancer Research 133
  • Surgery 113
Replace V. A. Miller with:
V. A. Miller United States
Jingyu Yu United States
Francisco Javier Ramos Spain
Graham H.P. Richmond United Kingdom
Jean‐Christophe Eymard France
Philip Bonomi United States
Axel R. Hanauske Germany
Vladimir Vladimirov United States
Qingyuan Zhang China
Yuankai Shi China
Karen J. Ferrante relative to V. A. Miller United States V. A. Miller's profile →
Citations per field
00.5×1.5×2.4×
V. A. Miller · 1×
Citations per year

Countries citing papers authored by Karen J. Ferrante

Since Specialization
Citations

This map shows the geographic impact of Karen J. Ferrante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen J. Ferrante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen J. Ferrante more than expected).

Fields of papers citing papers by Karen J. Ferrante

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen J. Ferrante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen J. Ferrante. The network helps show where Karen J. Ferrante may publish in the future.

Co-authorship network of co-authors of Karen J. Ferrante

This figure shows the co-authorship network connecting the top 25 collaborators of Karen J. Ferrante. A scholar is included among the top collaborators of Karen J. Ferrante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen J. Ferrante. Karen J. Ferrante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 48
2 20
3 1
4 2
5 2
6 64
7 7
8 5
9 7
10 8
11 33
12
Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignanciesbreakdown →
830
13 49
14 74
15 8
16 73
17
Treatment of hepatocellular carcinoma with transjugular intrahepatic portosystemic shunting and chemoembolization.
1
18 10

About Karen J. Ferrante

Karen J. Ferrante is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Oncology, having authored 18 papers that have together received 1.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (8 papers), Estrogen and related hormone effects (5 papers) and Hormonal and reproductive studies (4 papers). The work is most often cited by research in Oncology (862 citations), Pulmonary and Respiratory Medicine (741 citations) and Cancer Research (133 citations). Karen J. Ferrante has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Sandra Silberman, Eric K. Rowinsky, Manuel Hidalgo, Lisa A. Hammond, Carolyn D. Britten, Sabine Eckhardt, Lillian L. Siu, Anthony W. Tolcher, John Nemunaitis and Chris H. Takimoto. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026